Real-world outcomes of patients with relapsed/refractory large B-cell lymphoma receiving second-line therapy in

Christopher P Fox1, William Townsend2, John G Gribben3

  • 1School of Medicine University of Nottingham Nottingham UK.

Ejhaem
|October 17, 2024
PubMed